GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Assertio Holdings Inc (NAS:ASRT) » Definitions » Cyclically Adjusted PB Ratio

Assertio Holdings (Assertio Holdings) Cyclically Adjusted PB Ratio : 0.08 (As of May. 15, 2024)


View and export this data going back to 1997. Start your Free Trial

What is Assertio Holdings Cyclically Adjusted PB Ratio?

As of today (2024-05-15), Assertio Holdings's current share price is $1.01. Assertio Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $12.81. Assertio Holdings's Cyclically Adjusted PB Ratio for today is 0.08.

The historical rank and industry rank for Assertio Holdings's Cyclically Adjusted PB Ratio or its related term are showing as below:

ASRT' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.06   Med: 1.89   Max: 24.79
Current: 0.08

During the past years, Assertio Holdings's highest Cyclically Adjusted PB Ratio was 24.79. The lowest was 0.06. And the median was 1.89.

ASRT's Cyclically Adjusted PB Ratio is ranked better than
94.9% of 667 companies
in the Drug Manufacturers industry
Industry Median: 1.88 vs ASRT: 0.08

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Assertio Holdings's adjusted book value per share data for the three months ended in Mar. 2024 was $1.414. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $12.81 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Assertio Holdings Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Assertio Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Assertio Holdings Cyclically Adjusted PB Ratio Chart

Assertio Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.40 0.11 0.17 0.32 0.08

Assertio Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 0.40 0.19 0.08 0.07

Competitive Comparison of Assertio Holdings's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Assertio Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Assertio Holdings's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Assertio Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Assertio Holdings's Cyclically Adjusted PB Ratio falls into.



Assertio Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Assertio Holdings's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.01/12.81
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Assertio Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Assertio Holdings's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.414/129.4194*129.4194
=1.414

Current CPI (Mar. 2024) = 129.4194.

Assertio Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201406 12.275 100.560 15.798
201409 17.949 100.428 23.131
201412 24.586 99.070 32.118
201503 24.121 99.621 31.336
201506 22.954 100.684 29.505
201509 22.638 100.392 29.184
201512 20.732 99.792 26.887
201603 19.657 100.470 25.321
201606 19.366 101.688 24.647
201609 18.885 101.861 23.994
201612 16.189 101.863 20.569
201703 14.783 102.862 18.600
201706 13.430 103.349 16.818
201709 12.610 104.136 15.672
201712 10.694 104.011 13.306
201803 12.979 105.290 15.953
201806 11.966 106.317 14.566
201809 15.165 106.507 18.427
201812 13.731 105.998 16.765
201903 12.967 107.251 15.647
201906 12.184 108.070 14.591
201909 12.317 108.329 14.715
201912 2.866 108.420 3.421
202003 4.134 108.902 4.913
202006 3.174 108.767 3.777
202009 2.835 109.815 3.341
202012 1.955 109.897 2.302
202103 2.424 111.754 2.807
202106 2.074 114.631 2.342
202109 2.171 115.734 2.428
202112 2.294 117.630 2.524
202203 2.467 121.301 2.632
202206 2.665 125.017 2.759
202209 2.799 125.227 2.893
202212 4.671 125.222 4.828
202303 4.503 127.348 4.576
202306 4.499 128.729 4.523
202309 2.040 129.860 2.033
202312 1.458 129.419 1.458
202403 1.414 129.419 1.414

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Assertio Holdings  (NAS:ASRT) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Assertio Holdings Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Assertio Holdings's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Assertio Holdings (Assertio Holdings) Business Description

Traded in Other Exchanges
N/A
Address
100 South Saunders Road, Suite 300, Lake Forest, IL, USA, 60045
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Executives
Daniel A. Peisert director, officer: President & CEO C/O ASSERTIO THERAPEUTICS, INC., 100 SOUTH SAUNDERS ROAD, SUITE 300, LAKE FOREST IL 60045
Paul Schwichtenberg officer: SVP and CFO 100 SOUTH SAUNDERS ROAD, SUITE 300, LAKE FOREST IL 60045
Ajay Patel officer: SVP and CAO 100 SOUTH SAUNDERS ROAD, SUITE 300, LAKE FOREST IL 60045
Sam Schlessinger officer: SVP, General Counsel 100 SOUTH SAUNDERS ROAD, SUITE 300, LAKE FORREST IL 60045
William Mckee director
Jeff L Vacirca director 4747 EXECUTIVE DRIVE, SUITE 510, SAN DIEGO CA 92121
Heather L Mason director 100 SOUTH SAUNDERS ROAD, SUITE 300, LAKE FOREST IL 60045
James L Tyree director 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064-6400
Crg Partners Iii - Parallel Fund (a) L.p. 10 percent owner C/O CAPITAL ROYALTY L.P., 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Mark Strobeck officer: EVP & Chief Operating Officer 460 EAST SWEDESFORD ROAD, SUITE 1050, WAYNE PA 19087
Crg Partners Iii L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Cr Group L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Andrea Heslin Smiley director 600 LEE ROAD, SUITE 100, WAYNE PA 19087
Megan C. Timmins officer: SVP, Gen Csl & Sec 600 LEE ROAD, SUITE 100, WAYNE PA 19087
Crg Partners Iii - Parallel Fund B (cayman) L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002

Assertio Holdings (Assertio Holdings) Headlines

From GuruFocus